A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease

✍ Scribed by Arnold E. Postlethwaite; Weng Kee Wong; Philip Clements; Soumya Chatterjee; Barri J. Fessler; Andrew H. Kang; Joseph Korn; Maureen Mayes; Peter A. Merkel; Jerry A. Molitor; Larry Moreland; Naomi Rothfield; Robert W. Simms; Edwin A. Smith; Robert Spiera; Virginia Steen; Kenneth Warrington; Barbara White; Frederick Wigley; Daniel E. Furst

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 244 KB
• Volume: 58
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.23501